Previous 10 | Next 10 |
Gainers: WLL +7.3% . RRD +7.1% . RDFN +5.1% . ASLN +3.2% . TRIP +3.1% . More news on: Whiting Petroleum Corporation, R.R. Donnelley & Sons Company, Redfin Corporation, Stocks on the move, , , News on ETFs Read more ...
YayYo (NASDAQ: YAYO ) +39% on entering into a new fleet partnership with LMP Automotive Holdings. More news on: YayYo, Inc., Solid Biosciences Inc., ASLAN Pharmaceuticals Limited, Stocks on the move, Read more ...
Gainers: ASLN +8.6% . NK +7.1% . SCS +5.5% . OBSV +2.8% . CTAS +2.8% . More news on: ASLAN Pharmaceuticals Limited, NantKwest, Inc., Steelcase Inc., Stocks on the move, , News on ETFs Read more ...
Deals and Financings Alphamab Oncology, a company developing eight bispecifics for oncology, plans to stage an IPO before the end of the year on the Hong Kong Exchange that could raise up to $350 million. Alphamab Oncology is a spin out from Suzhou Alphamab. The company plans to use the proc...
Gainers: Genesco (NYSE: GCO ) +33% . More news on: Genesco Inc., Wellesley Bancorp, Inc., Big Lots, Inc., Stocks on the move, Read more ...
SINGAPORE, Dec. 06, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Limited (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced the closing of its previously announced underwritten public offering of 5,893,206 American Depositary Shar...
Schmitt Industries (NASDAQ: SMIT ) +13% on $2M stock repurchase plan . More news on: Schmitt Industries, Inc., EyePoint Pharmaceuticals, Inc., Kodiak Sciences Inc., Stocks on the move, Read more ...
ASLAN Pharmaceuticals (NASDAQ: ASLN ) -50% on pricing equity offering. More news on: ASLAN Pharmaceuticals Limited, CBL & Associates Properties, Inc, Aldeyra Therapeutics, Inc., Stocks on the move, Read more ...
ASLAN Pharmaceuticals (NASDAQ: ASLN ) has priced its public offering of 5,124,527 American Depositary Shares (ADSs) at $2.50 per ADS, for expected gross proceeds of ~$12.8M. Each ADS represents five ordinary shares of ASLAN. More news on: ASLAN Pharmaceuticals Limited, Healthcare stocks ...
SINGAPORE, Dec. 03, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Limited (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that it has priced its previously announced underwritten public offering of 5,124,527 American Depositary ...
News, Short Squeeze, Breakout and More Instantly...
ASLAN Pharmaceuticals Limited Company Name:
ASLN Stock Symbol:
NASDAQ Market:
SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it received a letter (the “Lett...
In a preliminary review of blinded data from the ongoing TREK-DX study, 45% (10/22) of patients achieved at least a 90% reduction in their EASI score (EASI-90) after 16 weeks. 56% (5/9) of patients with prior inadequate response to dupilumab achieved EASI-90 and 56% (5/9) of patients ...